EXEL

$72.19-0.17%visit website

EXELIXIS, INC.

Market Cap

$17.6B

Live price × SEC shares (Oct 19, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.44

60mo monthly vs SPY

P/E (TTM)

21.6

TTM to Oct 2026 · diluted EPS

P/S (TTM)

7.1

TTM to Oct 2026 · revenue

P/B

9.6

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Jan 2, 2026	Q1 FY2026 Apr 3, 2026	Q2 FY2026 Jul 3, 2026	Q3 FY2026 Oct 2, 2026	TTM Oct 2, 2026
Revenue	598,663	610,812	628,690	658,696	2,496,861
Cost of revenue	26,481	19,953	20,657	26,233	93,324
Research & development	213,248	199,916	211,987	209,481	834,632
Selling, general & administrative	123,024	139,602	147,632	154,559	564,817
Operating income	235,216	251,341	248,414	268,423	1,003,394
Income tax	8,160	57,220	50,628	64,690	180,698
Net income	244,528	210,467	212,050	218,095	885,140
EPS (basic) ($)		0.81	0.85	0.88	3.45
EPS (diluted) ($)		0.79	0.82	0.85	3.34
Weighted avg. shares (basic)		258,329	250,808	246,756
Weighted avg. shares (diluted)		267,322	259,675	255,754

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 29, 2026, period ended Oct 2, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 63 more quarters, back to Mar 2010, with Tormere Pro.

Corporate Events (8-K)

10 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 29, 2026 accepted 4:09 PM ET	2.02Earnings release	Document SEC ↗
Sep 11, 2026 accepted 7:00 AM ET	8.01Other events	Document SEC ↗
Aug 31, 2026 accepted 4:18 PM ET	8.01Other events	Document SEC ↗
Aug 5, 2026 accepted 4:09 PM ET	2.02Earnings release	Document SEC ↗
May 29, 2026 accepted 4:05 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 5, 2026 accepted 4:07 PM ET	2.02Earnings release8.01Other events	Document SEC ↗
Feb 10, 2026 accepted 4:08 PM ET	2.02Earnings release	Document SEC ↗
Jan 12, 2026 accepted 4:22 PM ET	2.02Earnings release	Document SEC ↗
Nov 7, 2025 accepted 4:07 PM ET	5.02Officer / director change8.01Other events	Document SEC ↗
Nov 4, 2025 accepted 4:25 PM ET	2.02Earnings release8.01Other events	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

51%

W/W -4.0pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

0.09x

Avg Daily Selling (90d)

109 sh/day

Baseline Daily Selling

2,810 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-10	2026-08-12	Beckerle Mary C	Director	Sale	9,812	$53.66	$527K	16.1K	View
2026-06-01	2026-06-03	Eckhardt Sue Gail	Director	Sale	9,812	$50.14	$492K	16.1K	View
2026-06-01	2026-06-03	WYSZOMIERSKI JACK L	Director	Sale	3,925	$50.55	$198K	284.4K	View
2026-05-26	2026-05-28	Aftab Dana	EVP, Research and Development	Sale	43.5K	$50.35	$2.19M	594.7K	View
2026-05-20	2026-05-22	Haley Patrick J.	EVP, Commercial	Sale	32.1K	$49.81	$1.60M	357.6K	View